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 Abstract 
 Background: Progression is believed to be a common and important complication in acute 
stroke, and has been associated with increased mortality and morbidity. Reliable identification 
of predictors of early neurological deterioration could potentially benefit routine clinical care. 
The aim of this study was to identify predictors of early stroke progression using two indepen-
dent patient cohorts.  Methods: Two patient cohorts were used for this study – the first cohort 
formed the training data set, which included consecutive patients admitted to an urban teach-
ing hospital between 2000 and 2002, and the second cohort formed the test data set, which 
included patients admitted to the same hospital between 2003 and 2004. A standard definition 
of stroke progression was used. The first cohort (n = 863) was used to develop the model. Vari-
ables that were statistically significant (p  ! 0.1) on univariate analysis were included in the mul-
tivariate model. Logistic regression was the technique employed using backward stepwise re-
gression to drop the least significant variables (p  1 0.1) in turn. The second cohort (n = 216) was 
used to test the performance of the model. The performance of the predictive model was as-
sessed in terms of both calibration and discrimination. Multiple imputation methods were used 
for dealing with the missing values.  Results: Variables shown to be significant predictors of 
stroke progression were conscious level, history of coronary heart disease, presence of hyper-
osmolarity, CT lesion, living alone on admission, Oxfordshire Community Stroke Project classi-
fication, presence of pyrexia and smoking status. The model appears to have reasonable dis-
criminative properties [the median receiver-operating characteristic curve value was 0.72 (range 
0.72–0.73)] and to fit well with the observed data, which is indicated by the high goodness-of-
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fit p value [the median p value from the Hosmer-Lemeshow test was 0.90 (range 0.50–0.92)]. 
 Conclusion: The predictive model developed in this study contains variables that can be easily 
collected in practice therefore increasing its usability in clinical practice. Using this analysis ap-
proach, the discrimination and calibration of the predictive model appear sufficiently high to 
provide accurate predictions. This study also offers some discussion around the validation of 
predictive models for wider use in clinical practice.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Early neurological deterioration within the first few hours or days of stroke onset has 
been referred to as stroke progression. It is a common event that has been reported to occur 
in 20–40% of acute strokes, and is associated with increased mortality and morbidity  [1] . 
Stroke progression can be defined as a patient admitted to hospital with acute stroke whose 
neurological condition deteriorates over 48–72 h  [2] . Stroke progression is often characterised 
by a fall of  6 2 points on a neurological scale measuring stroke severity, such as the National 
Institute of Health Stroke Scale. An alternative, validated approach is to define progression as 
any significant deterioration in conscious level, speech, arm or leg power, or facial weakness 
 [2] . It is accepted that in stroke progression, neurological worsening takes place slowly with 
an amplification of previous deficits or appearance of new symptoms corresponding to the 
same vascular territory. Progression has been shown to be a common and important compli-
cation in acute stroke, which has also been linked to poor long-term outcome.
 Reliable identification of predictors of early neurological deterioration could potentially 
be of benefit for routine clinical care. Therefore, it is important to understand the mecha-
nism by which progression in stroke occurs and identify the factors that may be able to pre-
dict such an occurrence. Yet, the causes of stroke progression are largely unknown and the 
predictors identified in previous studies vary  [3, 4] . A previous case-control study using 873 
consecutive acute stroke admissions identified a history of diabetes and raised systolic blood 
pressure as predictors of stroke progression  [4] . However, another prospective study of 868 
patients with acute stroke found that the risk of early progression decreased as systolic blood 
pressure increased  [5] . This same study also showed that diabetes was a risk factor for early 
progression and initial stroke severity for late progression. A smaller study of 152 consecu-
tive patients with first-ever ischaemic strokes showed that high levels of glucose on admis-
sion and brain swelling on the first computed tomography (CT) were the predictors of pro-
gression  [6] . A more recent study of 196 patients with ischaemic stroke identified blood urea 
nitrogen or creatinine as a predictor of stroke progression  [7] . Another study investigating 
133 lacunar stroke patients suggested that hypertriglyceridaemia may be a possible predictor 
of stroke progression  [8] . The aim of this study was to identify reliable predictors of early 
neurological deterioration in stroke. 
 Patients and Methods 
 Consecutive patients admitted to an urban teaching hospital with a diagnosis of stroke 
between 2000 and 2002, and subsequently between 2003 and 2004, were registered to a re-
search database. Baseline data on stroke characteristics, stroke severity and early neurologi-
cal deterioration were collected prospectively during both periods. This created two patient 
cohorts for this study – the first cohort formed the training data set and included 1,029 con-
secutive patients admitted to hospital, and the second cohort formed the test data set and 
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included 219 patients admitted to the same hospital. Only patients with complete outcome 
data were assessed in the analysis – 863 patients in the training data set and 216 patients in 
the test data set. With respect to acute medical management, patients received aspirin after 
CT, hypertension was not actively managed and premorbid antihypertensives were usually 
withheld for at least 72 h. No patients in the study group received thrombolysis.
 Stroke progression was defined as a  6 2-point worsening in the Scandinavian Stroke 
Scale (SSS) in either conscious level, arm, leg or eye movement scores, and/or a  6 3-point SSS 
worsening in speech score within 72 h of hospital admission  [9] . Outcome assessment was 
conducted 3 days after stroke.
 The training data set was used to develop the predictive model. Clinical opinion and the 
existing literature were used to reduce the number of variables collected at baseline to those 
considered potentially predictive of stroke progression. Univariate analysis was then con-
ducted between these potentially predictive variables and the outcome variable to determine 
which should be included in the model  [10, 11] . The variables that were statistically signifi-
cant (p  ! 0.1) on univariate analysis were included in the multivariate model. Logistic regres-
sion was the technique employed using backward stepwise regression to drop the least sig-
nificant variables (p  1 0.1) in turn.
 The performance of the model was investigated using the test data set and assessed in 
terms of both calibration and discrimination  [12] . It is the area under a receiver-operating 
characteristic (ROC) curve which provides an assessment of how good the model is in dis-
criminating between individuals with and without the outcome  [10] . The calibration of the 
model, which is comparing the observed proportion of events against the predicted proba-
bilities, was tested using the Hosmer-Lemeshow test.
 Multiple imputation methods were used for dealing with the missing values in both data 
sets. It was assumed that the missing data on the potentially prognostic variables were missing 
at random. This assumes that the probability that a value is missing is dependent on the values 
of variables that were actually collected and not independent of patient characteristics. Mul-
tiple imputation allows for the uncertainty about the missing data by creating 10 different plau-
sible imputed data sets and appropriately combining results obtained from each of them  [13] .
 Two predictive models were developed and validated using observed and imputed data 
sets. All analyses were carried out in Stata 11.
 Results 
 Stroke progression was recorded in 197 (23%) and 40 patients (18.5%) in the training and 
test data sets, respectively. Clinical opinion identified 27 variables as potentially predictive 
of stroke progression ( table 1 ). Overall, the characteristics of the patients in the two cohorts 
were similar ( table 1 ). The majority of patients were previously independent, with approxi-
mately 50% of the patients with hypertension and one third of patients having had a previous 
stroke. Co-morbidities such as atrial fibrillation, cardiac failure and diabetes were recorded 
in a minority of the patients. Patients who had a haemorrhage stroke were not recruited to 
the test cohort of patients. 
 Data on age, gender, conscious level, living alone, Oxfordshire Community Stroke Project 
(OCSP) classification, previous independence, type of CT lesion and the side of the lesion were 
complete for all patients. Of the 27 prognostic variables, 18 variables had incomplete data. Data 
on arm power, atrial fibrillation, abnormal physiological features, diabetes, history of coronary 
heart disease, hypoxia, hypertension, leg power, maximum systolic blood pressure, minimum 
systolic blood pressure, pyrexia, hyperglycaemia, previous stroke, previous transient isch-
aemic attack, smoking status, alcohol intake, osmolarity and verbal score were missing in 
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Table 1. P atient demographics and clinical variables
Training data set 
(n = 863)
Test data set 
(n = 216)
Age (mean 8 SD), years 69.0813.3 69.9813.5
Missing –
Systolic blood pressure (mean 8 SD), mm Hg
Min. 128.2823.4 not available
Missing 12 (1.4%) –
Max.1 174832.5 152.1829.4
Missing 14 (1.6%) –
Time from onset (median, IQR),  h 2 (1–8) 6 (2–12)2
Gender
Male 434 (50.3%) 97 (45.0%)
Female 429 (49.7%) 119 (55.1%)
Missing – –
Lives alone
Yes 284 (32.9%) 73 (33.8%)
No 579 (67.1%) 143 (66.2%)
Missing – –
Previous independence
Yes 695 (80.5%) 178 (82.4%)
No 168 (19.5%) 38 (17.8%)
Missing – –
Verbal score
<6 SSS score 154 (17.8%) 62 (28.7%)
6–12 SSS score 709 (82.2%) 154 (71.3%)
Arm power
0–2 SSS score 218 (25.3%) 66 (30.6%)
3–5 SSS score 644 (74.7%) 150 (69.4%)
Missing 1 (0.1%) –
Leg power
0–2 SSS score 309 (35.8%) 56 (25.9%)
3–5 SSS score 554 (64.2%) 160 (74.1%)
Conscious level
Reduced 103 (11.9%) 29 (13.4%)
Normal 760 (88.1%) 187 (86.6%)
Hypertension
Yes 417 (48.3%) 107 (49.5%)
No 428 (49.6%) 109 (50.5%)
Missing 18 (2.1%) –
Atrial fibrillation
Yes 95 (11.0%) 22 (10.2%)
No 744 (86.2%) 194 (89.8%)
Missing 24 (2.8%) –
Cardiac failure 
Yes 286 (33.1%) 76 (35.2%)
No 562 (65.1%) 140 (64.8%)
Missing 15 (1.7%) –
Diabetes
Yes 149 (17.3%) 32 (14.8%)
No 705 (81.7%) 184 (85.2%)
Missing 9 (1.0%) –
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Training data set 
(n = 863)
Test data set 
(n = 216)
Previous stroke
Yes 265 (30.7%) 48 (22.2%)
No 584 (67.7%) 168 (77.8%)
Missing 14 (1.6%) –
Previous TIA
Yes 122 (14.1%) 29 (13.4%)
No 702 (81.3%) 186 (86.1%)
Missing 39 (4.5%) 1 (0.46%)
Smoking status
No 241 (27.9%)  71 (32.9%)
Current 299 (34.7%) 78 (36.1%)
Ex-smoker 159 (18.4%) 51 (23.6%)
Missing data 164 (19.0%) 16 (7.4%)
Alcohol use
None 257 (29.8%) 99 (45.8%)
1–20 units 210 (24.3%) 44 (20.4%)
>20 units 108 (12.5%) 34 (15.7%)
Missing data 288 (33.4%) 39 (18.1%)
Side of lesion
Not classifiable 51 (5.91%) –
Left 389 (45.1%) 117 (54.2%)
Right 394 (45.7%) 99 (45.8%)
Posterior 29 (3.4%) –
Missing data – –
CT lesion
No scan 104 (12.1%) –
No appropriate lesion visible 193 (22.4%) 92 (42.6%)
Infarction 479 (55.5%) 124 (57.4%)
PICH 65 (7.5%) –
Other 22 (2.6%) –
Missing data – –
OCSP 
Not classifiable 69 (8.0%) –
Total ACS 203 (23.5%) 63 (29.2%)
Partial ACS 300 (34.8%) 92 (42.6%)
LACS 233 (27.0%) 46 (21.3%)
POCS 58 (6.7%) 15 (6.9%)
Missing data – –
Pyrexia
Yes 226 (26.2%) 67 (31.0%)
No 627 (72.7%) 148 (68.5%)
Missing data 10 (1.2%) 1 (0.5%)
Hyperglycaemia
Yes 134 (15.0%) 41 (19.0%)
No 634 (73.5%) 167 (77.3%)
Missing data 95 (11.0%) 8 (3.7%)
Hyperosmolarity
Yes 218 (25.3%) 51 (23.6%)
No 536 (62.1%) 129 (59.7%)
Missing data 109 (12.6%) 36 (16.7%)
Table 1 (continued)
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0.1–33.4% of the patients. The variables with the highest level of missing data were alcohol use 
(33.4%), smoking status (19.0%), hyperglycaemia (11.0%) and hyperosmolarity (12.6%;  table 1 ).
 On univariate analysis, age, alcohol intake, living alone, previous independence, verbal 
score, arm power, leg power, conscious level, history of coronary heart disease, smoking sta-
tus, CT lesion, OCSP classification, pyrexia, hyperosmolarity, one abnormal physiological 
sign, maximum and minimum systolic blood pressure, and side of lesion were significantly 
associated with stroke progression. The results of logistic regression of the imputed data set 
are shown in  table 2 . Conscious level, history of coronary heart disease, presence of hyper-
osmolarity, living alone on admission, OCSP classification and presence of pyrexia were as-
sociated with a significant increase in the odds of stroke progression. In particular, patients 
who experienced a total anterior circulation syndrome (ACS) were twice as likely to have a 
progression of stroke as those that had a partial ACS. In contrast, patients who had no lesion 
on their CT scan had significantly reduced odds of stroke progression in comparison to those 
with an infarction on CT scan; a similar effect was found in patients who were current or 
ex-smokers in comparison to those that were non-smokers. 
 A similar predictive model was developed, based only on the observed data in the train-
ing data set ( table 2 ). Both models shared common independent predictors, with the excep-
tion of lesion on CT and living alone; these were not shown to be predictive in the observed 
data model.
 When testing the performance of the predictive model based on the 10 test data sets gen-
erated by missing imputation, the median ROC value was 0.72 (range 0.72–0.73). This im-
plies that the model generated is moderately accurate and better than chance alone in pre-
dicting stroke progression. The median p value for the Hosmer-Lemeshow goodness-of-fit 
test was 0.90 (range 0.50–0.92), indicating a good fit between the model and the observed 
data. The observed number of patients with and without stroke progression is compared with 
the number expected in  table 3 . The performance of the predictive model was also tested us-
ing the training data set. The median ROC value 0.73 (range 0.72–0.74) was similar to that 
evaluated in the test data set. However, the median p value of 0.38 (range 0.06–0.70) for the 
Hosmer-Lemeshow goodness-of-fit test was lower indicating a poorer fit between the model 
and the observed data. 
Training data set 
(n = 863)
Test data set 
(n = 216)
Hypoxia
Yes 154 (17.8%) 30 (13.9%)
No 683 (79.1%) 185 (85.7%)
Missing data 26 (3.0%) 1 (0.5%)
Bad physiological feature
None recorded 385 (44.6%) 77 (35.7%)
≥1 feature 475 (55.0%) 119 (55.1%)
Missing data 3 (0.4%) 20 (9.3%)
E ntries are n (%), unless stated otherwise. LACS = Lacunar syndrome; POCS = posterior circulation 
syndrome; PICH = primary intracerebral haemorrhage; TIA = transient ischaemic attack.
1 For the test data set, only systolic blood pressure on admission is available.
2 Estimate from the literature [18]. 
Table 1 (continued)
111
Cerebrovasc Dis Extra 2011;1:105–114 
 DOI: 10.1159/000334473 
E X T R A
 Craig et al.: Predictive Model for Stroke Progression 
www.karger.com/cee
 © 2011 S. Karger AG, Basel 
 Published online: December 3, 2011 
 Discussion 
 This analysis suggests that conscious level, history of coronary heart disease, the lesion 
shown on CT scan, OCSP classification, living alone on admission, presence of hyperosmo-
larity, presence of pyrexia and smoking status are independent predictors of stroke progres-
sion. Some of the variables identified in this study have also been found to be predictive of 
stroke progression in other studies. However, some discrepancies do exist. For example, in 
this study, patients who experienced a total ACS were twice as likely to have a progression of 
stroke than those who experienced a partial ACS, while a previous study showed that neu-
rological progression was observed twice as often in patients with posterior circulation in-
farction than in those with anterior circulation infarction  [14] . Similarly, although reduced 
level of consciousness and a history of coronary heart disease have been associated with in-
creased risk of stroke progression in a few other studies  [2, 15] , in this study it was those pa-
Table 2. P redictive model for stroke progression
Predictors Model with imputed data (n = 863) M odel with observed data (n = 603)
OR (95% CI) p value OR (95% CI) p value 
Conscious level
Reduced 1.00 1.00
Normal 1.70 (0.95–3.00) 0.07 3.41 (1.51–7.72) <0.01
Coronary heart disease
No 1.00 1.00
Yes 1.44 (1.01–2.10) 0.05 1.53 (0.99–2.36) <0.05
Hyperosmolarity
No 1.00 1.00
Yes 1.55 (1.03–2.32) 0.03 1.93 (1.24–3.02) <0.01
Lesion on CT scan
Infarction 1.00 (overall <0.01) –
No scan 0.72 (0.41–1.24) 0.23 –
No lesion visible 0.40 (0.23–0.70) <0.01 –
PICH 1.60 (0.90–2.90) 0.11 –
Other 0.85 (0.30–2.70) 0.79 –
Living alone
Yes 1.00 –
No 1.54 (1.05–2.25) 0.03 –
OCSP classification
Partial ACS 1.00 (overall <0.01) 1.00 (overall <0.01)
Not classifiable 0.44 (0.18–1.10) 0.08 0.16 (0.37–0.69) <0.01
Total ACS 2.30 (1.44–3.70) <0.01 2.56 (1.46–4.49) <0.01
LACS 0.81 (0.51–1.30) 0.37 0.58 (0.33–0.99) 0.05
POCS 0.74 (0.34–1.63) 0.45 0.67 (0.26–1.70) 0.40
Pyrexia
No 1.00 1.00
Yes 1.73 (1.17–2.55) 0.01 2.10 (1.29–3.30) <0.01
Smoker
Not 1.00 (overall 0.02) 1.00 (overall <0.01)
Current 0.63 (0.41–0.95) 0.03 0.59 (0.40–0.94) 0.03
Ex-smoker 0.56 (0.33–0.94) 0.03 0.46 (0.25–0.83) 0.01
Ove rall = Median p value; LACS = lacunar syndrome; POCS = posterior circulation syndrome;
PICH = primary intracerebral haemorrhage.
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tients that had a normal conscious level that appeared to have an increased odds of stroke 
progression. The way in which these variables were measured clinically and how they were 
put into the predictive model could account for these differences. Finding the variables not 
living alone and having a normal level of consciousness being predictive of stroke progres-
sion is considered unexpected. It may be that not living alone is associated with a higher 
level of frailty. This may also be the result of over-fitting (including too many variables in) 
the model resulting in the inclusion of apparently important predictors which are not actu-
ally independent predictors  [16] . Stroke care may have changed since the study was conduct-
ed between 2000 and 2004. Therefore, it would be interesting to assess the performance of 
the model in a more recent cohort of patients. However, differences in performance may be 
difficult to attribute to changes in stroke care. 
 In terms of calibration, the model showed good agreement between the predicted prob-
abilities of stroke progression and those actually observed. Evaluating the performance of 
predictive models in a new cohort of patients as opposed to the original cohort used to de-
velop the model is an important feature when testing the validity of predictive models. In 
this study, the calibration properties of the model were different when evaluated in the test 
data set as when evaluated in the training data set. One reason for this may be that there 
were differences although a comparison of the demographics of the patients in the two co-
horts suggests that they are similar. The test cohort contained only patients who had an 
ischaemic stroke and the care pathway between these two cohorts did differ. During the re-
cruitment of the first cohort of patients, the hospital implemented a new acute stroke unit 
which was in place for the second cohort. This may have resulted in a different distribution 
of outcomes in this patient population, which may have influenced the calibration of the 
model. The model appeared to be able to discriminate fairly accurately between those pa-
tients likely to progress and those who were not when using the test data set. A very similar 
ROC value was derived when the model was tested in the training set. However, it is impor-
tant to extend beyond the internal validation approach used in this study and investigate 
the model in not only a separate patient cohort, but a cohort that is from a different popula-
Table 3. P redicted probabilities, observed and expected numbers (medians) by decile1
Decile Predicted 
probabilities
Observed 
progression 
Expected 
progression 
Observed no 
progression 
Expected no 
progression 
Total
1 0.05 2.0 1.1 23.0 23.9 25.0
2 0.07 1.0 1.3 18.0 17.8 19.0
3 0.11 1.0 1.9 20.0 19.2 21.0
4 0.13 2.0 2.6 20.0 19.4 22.0
5 0.16 3.0 3.0 18.0 18.0 21.0
6 0.20 4.0 4.0 17.5 18.0 22.0
7 0.24 4.0 4.9 18.0 17.1 22.0
8 0.28 6.5 5.5 14.0 15.5 21.0
9 0.36 5.5 6.9 16.5 15.1 22.0
10 0.53 11.0 8.9 10.0 12.0 21.0
1  This goodness-of-fit table shows the observed proportion of events against the predicted probability 
for 10 groups of equal size. For a perfectly fitted model, the observed proportions of events and predicted 
probability should create a 45° line, i.e. the slope is 1. This table is accompanied by the Hosmer-Lemeshow 
test giving a p value of 0.90, indicating that there is minimal difference between the observed and pre-
dicted event probabilities.
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tion. This would challenge the external validity and generalisability of the model as opposed 
to assessing internal validation, which may result in the performance of the model being 
overly optimistic. This reinforces the inherent difficulty with predictive modelling – how 
feasible is it to have one model apply to all patient subgroups across different models of care 
and countries  [17] ? Indeed, a few studies attempted to investigate how prognostic variables 
may vary across subgroups of patients or by the different causes of stroke. One study identi-
fied that different factors were associated with neurological worsening in different causes 
of stroke  [15]. 
 Predictive models for patients with acute stroke can be useful in informing patient man-
agement and a number of predictive models in stroke research exist. A common limitation 
in this area is the management of data sets with data on potential prognostic factors missing. 
A standard approach to manage this is to conduct a complete case analysis whereby patients 
that have missing data are excluded from the analysis. This could lead to the exclusion of a 
defined subset of patients, for example unconscious patients, where it has not been possible 
to ascertain their smoking habits. The alternative approach, multiple imputation, as used in 
this study, has not only increased the statistical power of the analysis but also eliminated the 
bias associated with excluding patients in a complete case analysis. The increased power in 
the imputed data set resulted in two additional factors found to be significant. Also, on com-
paring the models based on imputed and observed training data, the confidence intervals of 
the odds ratios are narrower in model based on imputed data, especially for conscious level 
and OCSP classification. This is to be expected since these variables did not have any miss-
ing data. By using multiple imputation, a technique not yet considered standard in managing 
missing data, this analysis minimises the bias associated with the more commonly used 
complete case approach. This study also highlights some of the recognised methodological 
challenges in prognostic research, such as validity and credibility of models in clinical prac-
tice. 
 Conclusion 
 The predictive model developed in this study contains variables that can be easily col-
lected in practice, therefore increasing its clinical applicability. This analysis shows that con-
scious level, a history of coronary heart disease, presence of hyperosmolarity, the lesion 
shown on CT scan, living alone on admission, OCSP classification, presence of pyrexia and 
smoking status are independent predictors of stroke progression. Using this analysis ap-
proach, the discrimination and calibration of the predictive model appear sufficiently high 
to provide accurate predictions.
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